Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 501 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Daiichi Sankyo launches dysuria therapy in China

Silodosin works by inhibiting the alpha 1A-adrenergic receptor and relieving tension in the prostate, lessening pressure and reducing urethral resistance. Kissei Pharmaceutical discovered silodosin, a selective alpha 1A-adrenoceptor